featured
SGLT2 Inhibitors vs GLP-1 Receptor Agonists and Clinical Outcomes in Patients With Diabetes With or Without Atrial Fibrillation
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The Journal of Clinical Endocrinology and Metabolism
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
SGLT2 inhibitors vs. GLP-1 receptor agonists and clinical outcomes in patients with diabetes with/without atrial fibrillation
J. Clin. Endocrinol. Metab. 2024 Mar 11;[EPub Ahead of Print], YH Chan, TF Chao, SW Chen, HF Lee, PR Li, YH Yeh, CT Kuo, LC See, GYH LipFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.